Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector

Aucoin, 2008, Critical assessment of current adeno-associated viral vector production and quantification methods, Biotechnol Adv, 26, 73, 10.1016/j.biotechadv.2007.09.001 Mueller, 2008, Clinical gene therapy using recombinant adeno-associated virus vectors, Gene Ther, 15, 858, 10.1038/gt.2008.68 Atchison, 1965, Adenovirus-associated defective virus particles, Science, 149, 754, 10.1126/science.149.3685.754 Buller, 1981, Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication, J Virol, 40, 241, 10.1128/jvi.40.1.241-247.1981 Xiao, 1998, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J Virol, 72, 2224, 10.1128/JVI.72.3.2224-2232.1998 Grimm, 1998, Novel tools for production and purification of recombinant adenoassociated virus vectors, Hum Gene Ther, 9, 2745, 10.1089/hum.1998.9.18-2745 Matsushita, 1998, Adeno-associated virus vectors can be efficiently produced without helper virus, Gene Ther, 5, 938, 10.1038/sj.gt.3300680 Booth, 2004, Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids, Gene Ther, 11, 829, 10.1038/sj.gt.3302226 Conway, 1999, High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap, Gene Ther, 6, 986, 10.1038/sj.gt.3300937 Hwang, 2003, High titer recombinant adeno-associated virus production using replication deficient herpes simplex viruses type 1, Mol Ther, 7, S14, 10.1016/S1525-0016(16)40477-6 Kang, 2009, An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes, Gene Ther, 16, 229, 10.1038/gt.2008.158 Thomas, 2009, Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells, Hum Gene Ther, 20, 861, 10.1089/hum.2009.004 Aslanidi, 2009, An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells, Proc Natl Acad Sci USA, 106, 5059, 10.1073/pnas.0810614106 Cecchini, 2008, Toward exascale production of recombinant adeno-associated virus for gene transfer applications, Gene Ther, 15, 823, 10.1038/gt.2008.61 Kohlbrenner, 2005, Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system, Mol Ther, 12, 1217, 10.1016/j.ymthe.2005.08.018 Negrete, 2008, Large-scale production of recombinant adeno-associated viral vectors, Methods Mol Biol, 433, 79, 10.1007/978-1-59745-237-3_5 Negrete, 2007, Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system, J Gene Med, 9, 938, 10.1002/jgm.1092 Urabe, 2002, Insect cells as a factory to produce adeno-associated virus type 2 vectors, Hum Gene Ther, 13, 1935, 10.1089/10430340260355347 Urabe, 2006, Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells, J Virol, 80, 1874, 10.1128/JVI.80.4.1874-1885.2006 Durocher, 2007, Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells, J Virol Methods, 144, 32, 10.1016/j.jviromet.2007.03.014 Hildinger, 2007, High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells, Biotechnol Lett, 29, 1713, 10.1007/s10529-007-9441-3 Park, 2006, Scalable production of adeno-associated virus type 2 vectors via suspension transfection, Biotechnol Bioeng, 94, 416, 10.1002/bit.20776 Grieger, 2006, Production and characterization of adeno-associated viral vectors, Nat Protoc, 1, 1412, 10.1038/nprot.2006.207 Thomas, 2005, Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung, Proc Natl Acad Sci USA, 102, 5679, 10.1073/pnas.0502067102 Davidoff, 2004, Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock, J Virol Methods, 121, 209, 10.1016/j.jviromet.2004.07.001 Kaludov, 2002, Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography, Hum Gene Ther, 13, 1235, 10.1089/104303402320139014 Zolotukhin, 2002, Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors, Methods, 28, 158, 10.1016/S1046-2023(02)00220-7 Zolotukhin, 1999, Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther, 6, 973, 10.1038/sj.gt.3300938 McCarty, 2001, Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis, Gene Ther, 8, 1248, 10.1038/sj.gt.3301514 Chadeuf, 2000, Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome, J Gene Med, 2, 260, 10.1002/1521-2254(200007/08)2:4<260::AID-JGM111>3.0.CO;2-8 Sonntag, 2010, A viral assembly factor promotes AAV2 capsid formation in the nucleolus, Proc Natl Acad Sci USA, 107, 10220, 10.1073/pnas.1001673107 Lock, 2010, Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale, Hum Gene Ther, 21, 1259, 10.1089/hum.2010.055 Vandenberghe, 2010, Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing, Hum Gene Ther, 21, 1251, 10.1089/hum.2010.107 Xiao, 1992, Characterization of adeno-associated virus replication and integration Maguire, 2008, Safety and efficacy of gene transfer for Leber's congenital amaurosis, N Engl J Med, 358, 2240, 10.1056/NEJMoa0802315 Rabinowitz, 2002, Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, J Virol, 76, 791, 10.1128/JVI.76.2.791-801.2002